Pharma Firms Reject Anthropic's Data Requests, Making Data the Moat for AI Drug Discovery
Hesamation · x · 2026-07-07
A blogger pointed out that Anthropic was unanimously rejected by major pharmaceutical companies when requesting data, arguing this is a primary reason why AI has triumphed in software but has yet to make major scientific discoveries. The analysis suggests pharma companies recognize data as their moat and refuse to hand it over. The blogger further predicts more companies will realize this and turn to open-source solutions to 'own their weights'.
Related event: Anthropic Denied Data Access by Big Pharma(2 posts)→
More from Companies & People
- Kunlun Spins Out Riemann Dynamics, Unveils World Action Model for Robotics — 0xAllen_ · 2026-07-21
- Qdrant co-hosts a Munich meetup on search, retrieval, and agentic RAG on July 23 — qdrant_engine · 2026-07-21
- Jamie Dimon says bureaucracy, not AI, is the real system crushing intelligence — r0ck3t23 · 2026-07-21
- Sophos joins Anthropic’s Project Glasswing to use Claude Mythos 5 for vulnerability hunting — TechNadu · 2026-07-21
- OpenAI and Anthropic’s internal models are said to be far stronger than today’s public systems — scaling01 · 2026-07-21
- A developer’s Codex usage is draining pooled enterprise credits at a small company — Distinct_Relation_62 · 2026-07-21